CRBP Corbus Pharmaceuticals
- 43.4450
- -1.7550-3.88%
Corbus Pharmaceuticals News
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Salzmann Peter
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HOLMER ALAN F
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jenkins John Kenneth
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jacques Rachelle Suzanne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Altmeyer Anne
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ben Yong
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CATLIN AVERY W
Corbus Pharmaceuticals | 8-K: Current report
Corbus Pharmaceuticals | 8-K: Current report
Corbus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Corbus Pharmaceuticals | 10-Q: Quarterly report
Corbus Pharmaceuticals | 8-K: Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Corbus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Sean F.
Corbus Pharmaceuticals | DEFA14A: Others
Corbus Pharmaceuticals | 8-K: Current report
Corbus Pharmaceuticals | ARS: Annual Report to Security Holders
Corbus Pharmaceuticals | DEFA14A: Others
Corbus Pharmaceuticals | DEF 14A: Definitive information statements
Corbus Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Corbus Pharmaceuticals | EFFECT: Others
Analysis
Price Target
No Data
